NCT01270828

Brief Summary

The purpose of the study is to explore the safety and efficacy of a new once a day pregabalin formulation versus placebo for patients with post herpetic neuralgia (Shingles)

Trial Health

98
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Strong global presence with extensive site network
Enrollment
806

participants targeted

Target at P75+ for phase_3

Timeline
Completed

Started Mar 2011

Typical duration for phase_3

Geographic Reach
16 countries

141 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 4, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 5, 2011

Completed
2 months until next milestone

Study Start

First participant enrolled

March 1, 2011

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2014

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2014

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

January 13, 2016

Completed
Last Updated

January 28, 2021

Status Verified

December 1, 2015

Enrollment Period

3.5 years

First QC Date

January 4, 2011

Results QC Date

October 1, 2015

Last Update Submit

January 26, 2021

Conditions

Keywords

Control Release Pregabalin in Post Herpetic Neuralgia

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Loss of Therapeutic Response.

    Loss of Therapeutic Response (LTR) is defined as \<30% pain response relative to the single blind phase baseline or patient discontinuation due to lack of efficacy or adverse events in the double blind phase of the study. For the calculation of \<30% pain response relative to baseline, baseline will be defined as the mean of the last 7 observations prior to the start of SB treatment, which will be compared with the 7 days rolling average of pain response in DB phase. Participants may be discontinued due to lack of efficacy in this study at the discretion of the study physician.

    13 Weeks

Secondary Outcomes (16)

  • Participants With Secondary LTR Based on 5 Day Rolling Average Diary Results

    13 Weeks

  • Percentage of Participants With 30% Reduction in the Mean Pain Score.

    13 Weeks

  • Percentage of Participants With 50% Reduction in the Mean Pain Score.

    13 Weeks

  • Change From Baseline to Endpoint in Weekly Mean Pain Score.

    SB Baseline (Enrollment) to Week 19 and DB Baseline (Week 6) to Week 19

  • Change in the Weekly NRS-Pain (1-Week Recall).

    SB Baseline (Enrollment) to Week 19 and DB Baseline (Week 6) to Week 19

  • +11 more secondary outcomes

Study Arms (2)

Pregablain CR tablet 82.5 to 660mg

EXPERIMENTAL
Drug: Pregabalin

Placebo

PLACEBO COMPARATOR
Drug: placebo

Interventions

Tablets, 82.5 to 660mg, once per day. Duration: 19 weeks

Pregablain CR tablet 82.5 to 660mg

Placebo, 82.5 to 660mg, once per day. Duration: 13 weeks

Placebo

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients must have pain present for more than 3 months after the healing of the herpes zoster skin rash.
  • At screening (V1) and enrollment (V2), patients must have a score of greater than or equal to 4 on the Pain Numeric Rating Scale (1 week recall period).
  • At enrollment (V2), at least 4 pain diaries must be completed satisfactorily within the last 7 days and the average pain score must be greater than or equal to 4.
  • Male or female of any race, at least 18 years of age, and using appropriate methods of contraception

You may not qualify if:

  • Creatinine clearance \<30 mL/min (estimated from serum creatinine).
  • Skin conditions in the affected dermatome that could alter sensation
  • Pregabalin use in the last 30 days. Subjects taking pregabalin in the last 30 days should be washed out of pregabalin for at least 30 days prior to screening visit. Patients who had not responded to pregabalin

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (146)

Fundamental Research

Gulf Shores, Alabama, 36542, United States

Location

Radiant Research, Inc.

Chandler, Arizona, 85224, United States

Location

Elite Clinical Studies, LLC

Phoenix, Arizona, 85018, United States

Location

HOPE Research Institute

Phoenix, Arizona, 85018, United States

Location

The Pain Center of Arizona

Phoenix, Arizona, 85018, United States

Location

The Pain Center of Arizona

Phoenix, Arizona, 85027, United States

Location

Genova Clinical Research

Tucson, Arizona, 85704, United States

Location

Larry Watkins, M.D. (Private Practice)

Little Rock, Arkansas, 72205, United States

Location

Lynn Institute of the Ozarks

Little Rock, Arkansas, 72205, United States

Location

Hearne Family Practice Clinic

Little Rock, Arkansas, 72206, United States

Location

Center for Clinical Research, Inc

Carmichael, California, 95608, United States

Location

Community Medical Providers

Clovis, California, 93611, United States

Location

Sierra Medical Research

Clovis, California, 93612, United States

Location

Inland Pain Medicine

Colton, California, 92324, United States

Location

The Helm Center

Laguna Hills, California, 92637, United States

Location

University of Southern California

Los Angeles, California, 90033, United States

Location

USC IDS Pharmacy

Los Angeles, California, 90089, United States

Location

Translational Research Group, Inc

North Hollywood, California, 91606, United States

Location

George J. Rederich, M.D., Incorporated

Redondo Beach, California, 90277, United States

Location

Integrated Research Group, Inc.

Riverside, California, 92506, United States

Location

Drug Shipmnent Only Aristotelis T. Laliotis, M.D. Integrated Research Center, Inc.

San Diego, California, 92117, United States

Location

Integrated Research Center, Inc.

San Diego, California, 92117, United States

Location

Center For Clinical Research, Inc.

San Francisco, California, 94115, United States

Location

Neurological Research Institute

Santa Monica, California, 90404, United States

Location

Foothills Pain Management Clinic, PS

West Covina, California, 91790, United States

Location

JEM Research Institute

Atlantis, Florida, 33462, United States

Location

Orthopedic Research Institute

Boynton Beach, Florida, 33472, United States

Location

Innovative Research of West Florida, Inc.

Clearwater, Florida, 33756, United States

Location

Clinical Research of West Florida, Inc.

Clearwater, Florida, 33765, United States

Location

Clinical Physiology Associates

Fort Myers, Florida, 33916, United States

Location

Health Care Family Rehab & Research Center

Hialeah, Florida, 33012, United States

Location

Laszlo Jozsef Mate, MD

North Palm Beach, Florida, 33408, United States

Location

Family Care Specialists

Ocala, Florida, 34471, United States

Location

Renstar Medical Research

Ocala, Florida, 34471, United States

Location

Compass Research, LLC

Orlando, Florida, 32806, United States

Location

Comprehensive Pain care of South Florida

Royal Palm Beach, Florida, 33411, United States

Location

Comprehensive Clinical Development Inc.

St. Petersburg, Florida, 33716, United States

Location

Neurology Clinical Research, Inc.

Sunrise, Florida, 33351, United States

Location

Clinical Research of West Florida, Inc.

Tampa, Florida, 33603, United States

Location

Meridien Research

Tampa, Florida, 33606, United States

Location

Injury Care Medical Center

Boise, Idaho, 83713, United States

Location

Millennium Pain Center, LLC

Bloomington, Illinois, 61701, United States

Location

(IP Shipping Address) Advocate Illinois Masonic Medical Center

Chicago, Illinois, 60657, United States

Location

Chicago Anesthesia Pain Specialists

Chicago, Illinois, 60657, United States

Location

Advanced Pain Care Clinic

Evansville, Indiana, 47714, United States

Location

Clinical Research Advantage

Evansville, Indiana, 47714, United States

Location

Global Scientific Innovations

Evansville, Indiana, 47714, United States

Location

Clinical Trials of America, Inc.

Monroe, Louisiana, 71201, United States

Location

Boston Clinical Trials

Boston, Massachusetts, 02135, United States

Location

Beacon Clinical Research

Brockton, Massachusetts, 02301, United States

Location

Infinity Medical Research, Inc.

North Dartmouth, Massachusetts, 02747, United States

Location

Michigan Head Pain & Neurological Institute

Ann Arbor, Michigan, 48104, United States

Location

QUEST Research Institute

Bingham Farms, Michigan, 48025, United States

Location

The Center for Pharmaceutical Research, PC

Kansas City, Missouri, 64114, United States

Location

Clinvest, A Division of Banyan Group, Inc

Springfield, Missouri, 65807, United States

Location

Medex Healthcare Research, Inc.

St Louis, Missouri, 63117, United States

Location

Montana Medical Research Inc

Missoula, Montana, 59808, United States

Location

Lincoln Internal Medicine Associates

Lincoln, Nebraska, 68516, United States

Location

Drug Shipment Only: Heartland Clinical Research, Inc.

Omaha, Nebraska, 68134, United States

Location

Heartland Clinical Research, Inc.

Omaha, Nebraska, 68134, United States

Location

The Office of Dr. Stephen H. Miller, MD

Las Vegas, Nevada, 89144, United States

Location

Albuquerque Clinical Trials, Inc.

Albuquerque, New Mexico, 87102, United States

Location

Dent Neurological Institute

Amherst, New York, 14226, United States

Location

SPRI Clinical Trials LLC

Brooklyn, New York, 11235, United States

Location

Medex Healthcare Research, Inc - Saint Louis

New York, New York, 10036, United States

Location

North American Partners In Pain Management

New York, New York, 11580, United States

Location

Asheville Neurology Specialists, PA

Asheville, North Carolina, 28806, United States

Location

Raleigh Neurology Associates, P.A.

Raleigh, North Carolina, 27607, United States

Location

The Center for Clinical Research

Winston-Salem, North Carolina, 27103, United States

Location

Radiant Research

Akron, Ohio, 44311, United States

Location

Providence Health Partners-Center for Clinical Research

Dayton, Ohio, 45439, United States

Location

Wells Institute for Health Awareness

Kettering, Ohio, 45429, United States

Location

Lynn Health Science Institute

Oklahoma City, Oklahoma, 73112, United States

Location

Mark A Fisher

Oklahoma City, Oklahoma, 73112, United States

Location

Pharmacorp Clinical Trials, Inc.

Charleston, South Carolina, 29412, United States

Location

Arlington Research Center, Inc.

Arlington, Texas, 76011, United States

Location

Lovelace Scientific Resources, Inc.

Austin, Texas, 78758, United States

Location

Radiant Research

Dallas, Texas, 75231, United States

Location

ClinRx Research, LLC

Richardson, Texas, 75080, United States

Location

Hillcrest Family Health Centers, Division of Clinical Research

Waco, Texas, 76710, United States

Location

Clinical Research Associates of Tidewater

Norfolk, Virginia, 23507, United States

Location

Clinical Investigation Specialists, Inc.

Kenosha, Wisconsin, 53142, United States

Location

DCC "St. Pantaleimon" OOD

Pleven, 5800, Bulgaria

Location

MHAT-Pleven

Pleven, 5800, Bulgaria

Location

MBALNP "Sveti Naum" EAD, Klinika po nervni bolesti za dvigatelni narushenia

Sofia, 1113, Bulgaria

Location

Vtora Mnogoprofilna Bolnitsa za Aktivno Lechenie ¿ Sofia, AD, Sofia, Nevrologichno otdelenie

Sofia, 1202, Bulgaria

Location

MBAL "Tokuda Bolnitsa", Otdelenie po nevrologiya

Sofia, 1407, Bulgaria

Location

Universitetska mnogoprofilna bolnitsa za aktivno lechenie Aleksandrovska, Klinika po Nevrologia

Sofia, 1431, Bulgaria

Location

Reumalab S.A.S

Medellín, Antioquia, Colombia

Location

Centro de Investigacion y Atencion Para la Salud Mental S.A. - CESAME

Bogota, Cundinamarca, 0, Colombia

Location

Fundacion Cardiovascular de Colombia

Floridablanca, Santander Department, 0, Colombia

Location

Opca bolnica Karlovac

Karlovac, Karlovacka Županija, 47000, Croatia

Location

Klinicki Bolnicki Centar Osijek

Osijek, Osjecko-baranjska Županija, 31000, Croatia

Location

Opca bolnica "Dr. Ivo Pedisic"

Sisak, Sisacko-moslavacka Županija, 44000, Croatia

Location

Neurologicka ambulance

Prerov I, 750 02, Czechia

Location

Aalborg Sygehus Nord

Aalborg, North Denmark, DK-900, Denmark

Location

Glostrup Hospital

Glostrup Municipality, DK-2066, Denmark

Location

Schmerzzentrum Frankfurt

Frankfurt am Main, Hesse, 60311, Germany

Location

pro scientia med im MARE Klinikum

Kiel-Kronshagen, Schleswig-Holstein, 24119, Germany

Location

DGS-Schmerzzentrum Eichstätt

Eichstätt, 85072, Germany

Location

Family Medicine

Hong Kong, Hong Kong

Location

Queen Elizabeth Hospital

Kowloon, Hong Kong

Location

Medanta Institute of Neurosciences

Gurgaon, Haryana, 122 001, India

Location

Manipal Hospital

Bangalore, Karnataka, 560 017, India

Location

M. S. Ramaiah Medical College and Hospitals

Bangalore, Karnataka, 560 054, India

Location

Mallikatta Neuro Centre

Mangalore, Karnataka, 575002, India

Location

Indraprastha Apollo Hospitals

New Delhi, 110 076, India

Location

"SYNEXUS POLSKA" Sp. z o.o.

Wroclaw, Lower Silesian Voivodeship, 50088, Poland

Location

Prof. dr hab. med. Leszek Szepanski Prywatna Praktyka Lekarska Gabinet Reumatologiczny

Lublin, Lublin Voivodeship, 20022, Poland

Location

"SYNEXUS POLSKA" Sp. z o.o. Oddzial w Warszawie

Warsaw, Masovian Voivodeship, 01192, Poland

Location

Niepubliczny Zaklad Opieki Zdrowotnej "Przychodnia Morena" Sp. z o.o.

Gdansk, Pomeranian Voivodeship, 80286, Poland

Location

"SYNEXUS POLSKA" Sp. z o.o. Oddzial w Gdyni

Gdynia, Pomeranian Voivodeship, 81384, Poland

Location

"SYNEXUS POLSKA" Sp. z o.o. Oddzial w Katowicach

Katowice, Silesian Voivodeship, 40040, Poland

Location

State Budgetary Health Institution of Yaroslavl region "Clinical hospital #10"

Yaroslavl, Russian Federation, 150023, Russia

Location

State Budgetary Educational Institution for higher Professional Training "Kazan State Medical Univer

Kazan', Tatarstan, Respublika, 119992, Russia

Location

Kazan State Medical University

Kazan', Tatarstan, Respublika, 420064, Russia

Location

GBUZ Nizhny Novgorod Regional Clinical Hospital N.A. Semashko

Nizhny Novgorod, 603126, Russia

Location

Clinic of Nervous Diseases M.I. Astvatsaturov

Saint Petersburg, 194175, Russia

Location

St. Petersburg State Healthcare Institution City Hospital # 40 Kurortnogo Administrativnogo Rajona

Saint Petersburg, 197706, Russia

Location

State Budgetary Educational Institution for Higher Professional Education

Smolensk, 214018, Russia

Location

State Budgetary Educational Institution for Higher Professional Education

Smolensk, 214019, Russia

Location

Clinic for Neurology

Belgrade, 11000, Serbia

Location

Clinic for Neurology

Niš, 18000, Serbia

Location

Euro-Neuro s.r.o., Neurologicka ambulancia

Bratislava, 831 03, Slovakia

Location

Univerzitna nemocnica Bratislava, Nemocnica sv. Cyrila a Metoda, Neurologicke oddelenie

Bratislava, 851 07, Slovakia

Location

MUDr. Eva Gasparova - neurologicka ambulancia

Hlohovec, 920 01, Slovakia

Location

Neurologicka ambulancia, Neuron-DT,s.r.o.

Žilina, 01001, Slovakia

Location

Nelson Mandela Academic Hospital Research Unit

Mthatha, Eastern Cape, 5099, South Africa

Location

Iatros International

Bloemfontein, 9301, South Africa

Location

Synapta Clinical Research Centre

Durban, 4001, South Africa

Location

Mzansi Ethical Research Centre

Middelburg, 1050, South Africa

Location

Jakaranda Pain Clinic

Pretoria, 0014, South Africa

Location

Probare

Lund, Skåne County, 222 22, Sweden

Location

Me3plus Clinical Trials

Gothenburg, 412 63, Sweden

Location

CTC, Sahlgrenska sjukhuset/SU

Gothenburg, 413 45, Sweden

Location

Center for Lakemedelsstudier

Malmo, 211 52, Sweden

Location

Bragee Medect AB

Stockholm, 115 22, Sweden

Location

Chang Gung Medical Foundation-Linkou Branch

Kwei Shan Town, Taoyuan County, 333, Taiwan

Location

National Taiwan University Hospital (Neurology)

Taipei, 100, Taiwan

Location

Public Institution "Institute of Neurology, Psychiatry and Narcology of AMS of Ukraine"

Kharkiv, 61068, Ukraine

Location

Kyiv City Clinical Hospital #4

Kyiv, 03110, Ukraine

Location

Lviv NMU n.a. Danylo Galytskyy

Lviv, 79013, Ukraine

Location

Regional Municipal Dermatovenerologic Dispensary

Lviv, 79013, Ukraine

Location

Crimean Republican Institution "Clinical Dermatovenerologic Dispensary"

Simferopol, 95006, Ukraine

Location

Municipal Establishment "Vinnitsa Regional Psychoneurological Hospital n.a. O.I. Yushchenko"

Vinnitsa, 21005, Ukraine

Location

Municipal Establishment "City Clinical Hospital #2", Neurology Department

Zaporizhzhya, 69068, Ukraine

Location

Related Publications (1)

  • Huffman CL, Goldenberg JN, Weintraub J, Sanin L, Driscoll J, Yang R, Chew ML, Scavone JM. Efficacy and Safety of Once-Daily Controlled-Release Pregabalin for the Treatment of Patients With Postherpetic Neuralgia: A Double-Blind, Enriched Enrollment Randomized Withdrawal, Placebo-Controlled Trial. Clin J Pain. 2017 Jul;33(7):569-578. doi: 10.1097/AJP.0000000000000445.

Related Links

MeSH Terms

Conditions

Neuralgia, Postherpetic

Interventions

Pregabalin

Condition Hierarchy (Ancestors)

NeuralgiaPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

gamma-Aminobutyric AcidAminobutyratesButyratesAcids, AcyclicCarboxylic AcidsOrganic ChemicalsAmino AcidsAmino Acids, Peptides, and Proteins

Results Point of Contact

Title
Pfizer ClinicalTrials.gov Call Center
Organization
Pfizer, Inc

Study Officials

  • Pfizer CT.gov Call Center

    Pfizer

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 4, 2011

First Posted

January 5, 2011

Study Start

March 1, 2011

Primary Completion

September 1, 2014

Study Completion

November 1, 2014

Last Updated

January 28, 2021

Results First Posted

January 13, 2016

Record last verified: 2015-12

Locations